Profile: Kimberly K Egan

Life Sciences

Biography: Life Sciences

Kim Egan is a pharmaceutical and product liability lawyer in the Washington, DC office DLA Piper. She has extensive experience with all aspects of new drug development, including pre-clinical and clinical trial development, clinical data review, data safety monitoring board issues, FDA approval of new molecular entities or line extensions, drug labeling issues, promotional issues, HIPAA and other patient privacy issues, and Advisory Committee preparations. She also advises companies on clinical trial issues that arise outside the United States, including global paediatric informed consent requirements, global requirements governing investigator payments, and global requirements governing clinical trials generally.

Ms Egan's practice also includes a wide variety of complex commercial litigation matters, including product liability matters, trade secret and business tort litigation, and contract disputes.